Evidence map›Paper›PMID 29081935›Full record

ArticlePediatric reports2017

Clinical heterogeneity in a family with

Cristina Olivieri, Anna Mondino, Matteo Chinello, Alessandra Risso, Enrico Finale, Marina Lanciotti, Andrea Guala

Open access · goldAbstract read
In one paragraph

Article in Pediatric reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. A Novel Variant and a Missense Variant Identified in theClinical, cosmetic and investigational dermatology · 2022
    Article
  4. Revesz syndrome revisited.Orphanet journal of rare diseases · 2020
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Cristina OlivieriDepartment of Public and Pediatric Health Sciences, University of Turin.
Anna MondinoDepartment of Public and Pediatric Health Sciences, University of Turin.
Matteo ChinelloDepartment of Pediatric Hematology and Oncology, Policlinico G.B. Rossi, Verona.
Alessandra RissoDepartement of Hematology, City of Health and Science, University of Turin.
Enrico FinaleUnit of Pediatrics, Castelli Hospital, Verbania.
Marina LanciottiDepartment of Pediatric Hematology Oncology and Bone Marrow Transplant, G. Gaslini Children's Hospital, Genoa, Italy.
Andrea GualaUnit of Pediatrics, Castelli Hospital, Verbania.
University of Turin · ITChildren's Research Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dyskeratosis congenita (DC) is an inherited bone marrow failure disorder characterized by mucocutaneous features (skin pigmentation, nail dystrophy and oral leukoplakia), pulmonary fibrosis, hematologic and solid malignancies. Its severe form, recognized as Hoyeraal-Hreidarsson syndrome (HHS), also includes cerebellar hypoplasia, microcephaly, developmental delay and prenatal growth retardation. In literature phenotypic variability among DC patients sharing the same mutation is wellknown. To our knowledge this report describes for the first time a family of DC patients, characterized by a member with features of classic DC and another one with some features of HHS, both with the same mutation in

Indexed as

Dyskeratosis Congenitalgene mutationHoyeraal-Hreidarsson Syndromephenotypic variability

Identifiers

PMID29081935
PMCPMC5643882
OpenAlexW2761000883

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.